Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for AtriCure (ATRC) over the last 16 years, with Q3 2025 value amounting to $205000.0.

  • AtriCure's Other Working Capital Changes rose 10942.1% to $205000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 39442.79%. This contributed to the annual value of $2.2 million for FY2024, which is 2947.47% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Other Working Capital Changes is $205000.0, which was up 10942.1% from -$2.4 million recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Other Working Capital Changes peaked at $3.9 million during Q1 2025, and registered a low of -$2.4 million during Q2 2025.
  • Over the past 5 years, AtriCure's median Other Working Capital Changes value was $424000.0 (recorded in 2021), while the average stood at $489052.6.
  • Per our database at Business Quant, AtriCure's Other Working Capital Changes plummeted by 36687.9% in 2021 and then surged by 39374.13% in 2023.
  • Quarter analysis of 5 years shows AtriCure's Other Working Capital Changes stood at $711000.0 in 2021, then crashed by 201.13% to -$719000.0 in 2022, then soared by 393.74% to $2.1 million in 2023, then soared by 55.4% to $3.3 million in 2024, then crashed by 93.75% to $205000.0 in 2025.
  • Its Other Working Capital Changes stands at $205000.0 for Q3 2025, versus -$2.4 million for Q2 2025 and $3.9 million for Q1 2025.